Business
Shadowfax IPO GMP Jumps Ahead Of Launch; Check Price Band And Key Details
New Delhi: Shadowfax Technologies Ltd, a well-known name in India’s logistics and delivery space, is set to enter the stock market this week with its much-awaited initial public offering (IPO). The company aims to raise up to Rs 1,907.27 crore through the issue which includes a fresh share sale as well as an offer for sale by existing investors.
When will the Shadowfax Technologies IPO open?
The IPO will open for subscription on January 20, 2026, giving investors a chance to bet on the fast-growing logistics sector, and will close on January 22, 2026, with the company slated to make its debut on the BSE and NSE on January 28, 2026.
IPO Price Band and Investment Details
The company has set the IPO price band at Rs 118 to Rs 124 per share, with a face value of Rs 10 each. Retail investors can apply for at least one lot consisting of 120 shares, which means an investment of Rs 14,880 at the upper end of the price band. ICICI Securities is managing the issue as the book-running lead manager, while Kfin Technologies has been appointed as the registrar.
IPO Price Band, Lot Size and Key Managers
The company has set the IPO price band at Rs 118–124 per share, with a face value of Rs 10 each. Retail investors can apply for a minimum of one lot comprising 120 shares, which means an investment of Rs 14,880 at the upper end of the price band. ICICI Securities is the book-running lead manager for the issue, while Kfin Technologies has been appointed as the registrar.
Shadowfax Technologies IPO GMP: What It Signals for Listing
Shadowfax Technologies’ unlisted shares are currently trading at around Rs 134 in the grey market, reflecting a premium of about 8.06 per cent over the IPO’s upper price band of Rs 124, according to market observers. This suggests that investors may see modest listing gains when the stock debuts on January 28, 2026. The allotment of shares is expected to be finalised on January 23, 2026.
It is important to note that the grey market premium (GMP) is driven purely by market sentiment and can change frequently. GMP indicates how much extra investors are willing to pay over the issue price before the stock officially lists.
How Shadowfax Plans to Use IPO Funds
Shadowfax Technologies intends to use the money raised from the fresh issue primarily to strengthen and expand its logistics network. Of the total proceeds, around Rs 423 crore will be spent on capital expenditure for building network infrastructure, while Rs 138.6 crore is earmarked for lease payments for new first-mile, last-mile and sortation centres. The company also plans to invest about Rs 88.6 crore in branding and marketing, with the remaining funds set aside for inorganic growth opportunities and general corporate needs.
The company has chosen the confidential pre-filing route for its IPO, a process that allows key details in the draft red herring prospectus (DRHP) to remain private until a later stage. This approach is becoming increasingly popular among Indian companies as it offers greater flexibility and room to fine-tune IPO plans before going public.
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
Ogra warns of strict action against illegal hoarding of petroleum products – SUCH TV
The Oil and Gas Regulatory Authority (Ogra) on Thursday warned of strict action against any individual or entity found involved in the illegal hoarding of petroleum products at unauthorised locations, particularly at places other than duly licensed oil depots and retail outlets of Oil Marketing Companies (OMCs).
In a statement, an Ogra spokesperson said: “Any premises found involved in the illegal storage of petroleum products will be sealed.”
The spokesperson assured the public that the country currently holds sufficient stocks of petroleum products to meet national demand and that there is no need for panic buying or hoarding.
In view of the prevailing geopolitical situation, the official said that the authorities are closely monitoring the petroleum supply chain to ensure the uninterrupted availability of products across the country.
“The existing stock position remains comfortable and well within the prescribed requirements,” read the statement.
Reports have indicated that certain elements may attempt to hoard petroleum products for profiteering under such circumstances, the spokesperson said, adding: “To curb such practices, all provincial chief secretaries have been requested to direct deputy commissioners (DCs) to conduct inspections within their respective jurisdictions.”
Meanwhile, teams of Ogra are actively monitoring the situation in the field, the official added.
Inspections are being carried out at oil depots and retail outlets to ensure the smooth supply of petroleum products and to prevent any malpractice, read the statement.
Ogra advised the public not to pay attention to rumours and to maintain normal consumption patterns, as the petroleum supply situation in the country remains stable.
Uninterrupted petroleum supply top priority: FinMin
Separately, Finance Minister Muhammad Aurangzeb has said that ensuring uninterrupted availability of petroleum products across the country is the government’s top priority.
The finance czar made the remarks while chairing a meeting of the committee to Monitor Petrol Prices in the Wake of the Emerging Situation in the region, constituted by Prime Minister Shehbaz Sharif, in Islamabad today.
The committee was briefed that national reserves remain at comfortable levels, with sufficient cover available for key products, and that there is no immediate cause for concern regarding the availability of petroleum products.
It reviewed multiple supply and pricing scenarios to ensure preparedness under different contingencies and to maintain stability in domestic energy supplies.
The committee will finalise its recommendations by tomorrow for onward submission to the prime minister.
It will continue to meet on a daily basis to monitor developments, review stock positions and supply chain movements, and ensure timely execution across all stakeholders.
The committee also noted that “war premium” dynamics and intensified competition for energy cargoes, particularly in Asian markets, could raise external account pressures if volatility persists.
The body reviewed ongoing efforts to strengthen supply assurance through diversified sourcing and logistics arrangements.
The committee also considered shipping and operational measures to reduce time lags, including facilitation of timely berthing and the use of available national shipping capacity where feasible.
To safeguard orderly market conditions, the committee discussed measures to deter hoarding, illegal storage, and diversion, including coordinated enforcement actions by provincial administrations in close collaboration with the Ogra and relevant agencies.
The committee emphasised that preventing outward smuggling and ensuring uninterrupted domestic distribution will remain a top operational priority, and that real-time field intelligence and strict action against violations will be maintained.
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
-
Sports1 week agoSri Lanka’s Shanaka says constant criticism has affected players’ mental health
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
